A carbon column-based liquid chromatography electrochemical approach to routine 8-hydroxy-2 '-deoxyguanosine measurements in urine and other biologic matrices: A one-year evaluation of methods

被引:166
作者
Bogdanov, MB [1 ]
Beal, MF
McCabe, DR
Griffin, RM
Matson, WR
机构
[1] Massachusetts Gen Hosp, Neurochem Lab, Serv Neurol, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02114 USA
[3] Cornell Univ, Coll Med, Dept Neurol & Neurosci, New York, NY USA
[4] ESA Inc, Chelmsford, MA USA
关键词
8-hydroxy-2 '-deoxyguanosine; carbon columns; chromatography; high-pressure liquid; urine; plasma; cerebrospinal fluid; DNA; free radicals;
D O I
10.1016/S0891-5849(99)00113-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
8-Hydroxy-2'-deoxyguanosine (80H2'dG) is a principal stable marker of hydroxyl radical damage to DNA. It has been related to a wide variety of disorders and environmental insults, and has been proposed as a useful systematic marker of oxidative stress. Analytic procedures for 80H2'dG in DNA digests are well established; however, routine measurement of free 8OH2'dG in other body fluids such as urine or plasma has been problematic. This has hindered its evaluation as a general clinical, therapeutic monitoring, or environmental assessment tool. Therefore, we developed a liquid chromatography electrochemical column-switching system based on the use of the unique purine selectivity of porous carbon columns that allows routine accurate measurement of 80H2'dG in a variety of biologic matrices. This paper describes the rationale of the system design and the protocols developed for 80H2'dG in urine, plasma, cerebrospinal fluid, tissue, DNA, saliva, sweat, kidney dialysis fluid, foods, feces, culture matrix, and microdialysates. Concentrations in both human and animal body fluids and tissues are reported. The system performance is discussed in the context of a 1-year evaluation of the methods applied to approximately 3600 samples, using internal quality control and external blind testing to determine long-term accuracy. The methods are reliable and accurate, and therefore should prove useful in assessing the role and utility of oxidative DNA damage in aging and human illness. (C) 1999 Elsevier Science Inc.
引用
收藏
页码:647 / 666
页数:20
相关论文
共 39 条
  • [1] Acworth I. N, 1997, COULOMETRIC ELECTROD, P3
  • [2] Acworth I.N., 1997, OXIDANTS ANTIOXIDANT, P23
  • [3] ENDOGENOUS OXIDATIVE DNA DAMAGE, AGING, AND CANCER
    AMES, BN
    [J]. FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 7 (3-6): : 121 - 128
  • [4] BERGTOLD DS, 1990, ADV EXP MED BIOL, V264, P311
  • [5] OXIDATIVE DAMAGE TO DNA IN PATIENTS WITH CYSTIC-FIBROSIS
    BROWN, RK
    MCBURNEY, A
    LUNEC, J
    KELLY, FJ
    [J]. FREE RADICAL BIOLOGY AND MEDICINE, 1995, 18 (04) : 801 - 806
  • [6] Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia
    Browne, SE
    Bowling, AC
    MacGarvey, U
    Baik, MJ
    Berger, SC
    Muqit, MMK
    Bird, ED
    Beal, MF
    [J]. ANNALS OF NEUROLOGY, 1997, 41 (05) : 646 - 653
  • [7] Oxidative damage to DNA in diabetes mellitus
    Dandona, P
    Thusu, K
    Cook, S
    Snyder, B
    Makowski, J
    Armstrong, D
    Nicotera, T
    [J]. LANCET, 1996, 347 (8999) : 444 - 445
  • [8] DEEGAN P, 1991, CARCINOGENESIS, V12, P865
  • [9] DISDAROGLU M, 1991, FREE RADIC BIOL MED, V10, P225
  • [10] Ferrante RJ, 1997, J NEUROCHEM, V69, P2064